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Abstract 
Background: Aerobic High Intensity Interval Training (HIIT) is safe in the general 
population and more efficient in improving fitness than continuous moderate 
intensity training. The body of literature examining HIIT in Multiple Sclerosis 
(MS) is expanding but to date a systematic review has not been conducted. The 
aim of this review was to investigate the efficacy and safety of HIIT in people 
with MS. 
Methods: A systematic search was carried out in September 2017 in EMBASE, 
MEDline, PEDro, CENTRAL and Web of Science Core collections using appropriate 
keywords and MeSH descriptors. Reference lists of relevant articles were also 
searched. Articles were eligible for inclusion if they were published in English, 
used HIIT, and included participants with MS. Quality was assessed using the 
PEDro scale. The following data were extracted using a standardised form: study 
design and characteristics, outcome measures, significant results, drop-outs, and 
adverse events.  
Results: Seven studies (described by 11 articles) were identified: four 
randomised controlled trials, one randomised cross-over trial and two cohort 
studies. PEDro scores ranged from 3-8. Included participants (n=249) were 
predominantly mildly disabled; one study included only people with progressive 
MS. Six studies used cycle ergometry and one used arm ergometry to deliver 
HIIT. One study reported six adverse events, four which could be attributed to 
the intervention. The other six reported that there were no adverse events. Six 
studies reported improvements in at least one outcome measure, however there 
were 60 different outcome measures in the seven studies. The most commonly 
measured domain was fitness, which improved in five of the six studies 
measuring aspects of fitness. The only trial not to report positive results 
included people with progressive and a more severe level of disability (Extended 
Disability Status Scale 6.0-8.0). 
Conclusion: HIIT appears to be safe and effective in increasing fitness in people 
with MS and low levels of disability. Further research is required to explore the 
effectiveness of HIIT in people with progressive MS and in those with higher 
levels of disability. 
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1 Introduction 
Exercise is a safe and feasible intervention for people with Multiple Sclerosis 
(MS) (Heine et al., 2015) and  is recommended for increasing cardiovascular 
fitness and muscular strength (Latimer-Cheung et al., 2013). Cardiovascular 
fitness in people with MS is lower compared to healthy individuals (Langeskov-
Christensen et al., 2015) and is inversely correlated with disease severity and 
impairment, with fitness decreasing as disability and fatigue rise (Heine et al., 
2014; Heine et al., 2016; Kuspinar et al., 2010; Marrie and Horwitz, 2010; Motl 
and Fernhall, 2012; Valet et al., 2016). Reviews of trials evaluating the effects 
of exercise in people with MS have indicated that exercise training is beneficial 
for increasing and maintaining cardiovascular fitness (Dalgas et al., 2008; 
Rietberg et al., 2005).   
Traditionally, continuous moderate intensity training programmes, to increase 
fitness and reduce cardiovascular disease risk factors in healthy adults, last 30-
60 minutes at 40-85% of maximal intensity, with higher intensities producing a 
greater increase in fitness (Garber et al., 2011). High Intensity Interval Training 
(HIIT), however, involves short bursts of exercise at very high intensity with 
either a complete or working rest in between bursts. Total time for training 
sessions typically last around 20 minutes, have 4-6 cycles of 80-95% of maximal 
effort for 1-4 minutes with a similar time of working recovery or rest (Cassidy et 
al., 2017; Kessler et al., 2012).   
Compared to continuous moderate intensity training, HIIT is more efficient in 
improving VO2 max in healthy individuals (Milanovic et al., 2015), people with 
coronary artery disease (Elliott et al., 2015), increased cardio-metabolic risk 
(Weston et al., 2014), and heart failure (Haykowsky et al., 2013; Ismail et al., 
2013; Smart et al., 2013; Wisloff et al., 2007). HIIT also produces greater or 
equal effects, to continuous moderate intensity training, in improving 
cardiovascular risk factors such as high blood pressure and altered glucose 
metabolism (Fleg, 2016). The main advantage of HIIT over continuous moderate 
intensity training is the shorter time required to achieve similar energy 
expenditure, and comparable, or greater benefits (Fleg, 2016). This is due to an 
increase in oxygen consumption after acute strenuous exercise known as Excess 
Post-exercise Oxygen Consumption (Gaesser and Brooks, 1984). Furthermore, 
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shorter exercise intervals of 2 minutes or less have been found to be more 
enjoyable than continuous moderate intensity training by participants due to the 
shorter duration of each burst at high intensity (Cassidy et al., 2017).   
Previous work examining the effect of HIIT in people with Parkinson’s found an 
increase in Brain Derived Neurotrophic Factor (BDNF) production, decrease 
parkinsonian rigidity and muscle tone (Marusiak et al., 2015), improved gait 
parameters (Pohl et al., 2003) and cognitive performance (Alves et al., 2014). In 
addition there is limited but positive evidence for using HIIT to improve walking 
endurance in stroke survivors (Boyne et al., 2015; Boyne et al., 2016). However, 
given that only one of five studies compared HIIT to another form of aerobic 
exercise (Boyne et al., 2016) indicates that HIIT is an emerging modality in these  
conditions.  
High intensity interval training has been recommended as a possible effective 
intervention for people with MS as it can allow people to exercise at higher 
intensities while avoiding thermosensitive reactions (Dalgas et al., 2008). Over 
the past several years there has been increasing interest in HIIT in MS and 
several interventional trials published; however no systematic review of HIIT in 
people with MS has been undertaken. Therefore the aim of this review was to 
establish the efficacy and safety of HIIT in people with MS.  
2 Methods 
An electronic search was undertaken of the following databases in September 
2017: EMBASE, MEDline, PEDro, CENTRAL and Web of Science Core collections.  
The search terms used can be seen in Table 1. The Boolean operators ‘AND’ and 
‘OR’ were used to combine searches as appropriate. No limits were placed on 
time of publication. The reference lists of included articles were also searched. 
Articles were eligible for inclusion if they were clinical trials that consisted of an 
aerobic intervention of HIIT alone or in combination with another type of 
exercise training (HIIT was defined as intervals of exercise of 5 minutes or less 
reaching an intensity of 80% or more of maximal effort in each interval (Fleg, 
2016)), included participants with MS, or if in a mixed population, data for 
people with MS were presented separately, and published in English. Articles 
were excluded if they were non-human studies, case studies, conference 
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abstracts or focused solely on resistance, core or balance training. To ensure 
relevant articles were included, if the abstract or title did not provide the 
exercise intensity, the methods of the articles were read.  
Table 1. Search strategy. 
Database Search terms 
Medline ((exp Multiple Sclerosis/) OR ((Multiple Sclerosis or relapsing 
remitting OR chronic progressive OR secondary progressive OR 
primary progressive).mp.)) AND ((High intensity interval 
training OR interval training OR High intensity interval exercise 
OR interval exercise OR aerobic interval training OR high 
intensity OR high-intensity OR exercise intensity OR HIIT OR 
HIT).mp.) 
Embase ((multiple sclerosis/) OR ((Multiple Sclerosis or relapsing 
remitting OR chronic progressive OR secondary progressive or 
primary progressive).mp.)) AND ((High intensity interval 
training OR interval training OR High intensity interval exercise 
OR interval exercise OR aerobic interval training OR high 
intensity OR high-intensity OR exercise intensity OR HIIT OR 
HIT).mp.) 
Web of Science 
core collections 
(TS=("Multiple sclerosis" OR "MS" OR "relapsing remitting" OR 
"chronic progressive" OR "secondary progressive" OR "primary 
progressive")) AND ( TS=("High intensity interval training" OR 
"Interval training" OR "High intensity interval exercise" OR 
"Interval exercise" OR "Aerobic interval training" OR "High 
intensity" OR “High-intensity” OR "HIIT" OR "HIT")) 
PEDro High intensity multiple sclerosis 
 
CENTRAL (((Multiple Sclerosis) OR (relapsing remitting) OR (chronic 
progressive) or (secondary progressive) OR (primary 
progressive)) OR (MeSH descriptor: [Multiple Sclerosis] explode 
all trees)) AND (((High intensity interval training) OR (interval 
training) or (High intensity interval exercise) OR (interval 
exercise) OR (aerobic interval training) OR (high intensity) OR 
(high-intensity) OR (exercise intensity) or (HIIT) or (HIT))) 
Abbreviations: exp: explode; mp: multi-purpose keyword search; TS: Topic Search  
 
Quality assessment was carried out using the PEDro scale which is valid and 
reliable in methodological rating of studies (de Morton, 2009; Maher et al., 
2003). The PEDro scale has 11 criteria but produces a score out of ten as no 
point is awarded for listing of exclusion and inclusion criteria. Included articles 
were assessed by at least two reviewers (EC, EHC, LP). Where there was 
disagreement between reviewers this was settled by discussion. Although 
primarily for Randomised Controlled Trials (RCTs), the PEDro scale can be used 
for cohort studies, with points deducted due to lack of randomisation. This has 
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been done in previous systematic reviews of multiple sclerosis interventions 
(Kjolhede et al., 2012; Martin-Valero et al., 2014). 
The following data were extracted from each article into a standardised form: 
authors, date of publication, study design, sample size, type of MS, disability 
level, number of drop-outs, adverse events, length of intervention, frequency of 
training, type of training, number of intervals per session, target intensity 
ranges, total time spent in high intensity during the intervention, additional 
exercise training modalities employed, outcome measures and results. 
 
3 Results 
The electronic search identified 935 potential articles and hand searching of 
relevant reference lists provided one additional article. After the removal of 264 
duplicates, the remaining 671 articles were screened by title and abstract.  
From titles alone, 575 were excluded. Following this, another 58 were excluded 
by abstract. The full text of 38 articles were read for eligibility by at least two 
members of the research team and 27 were subsequently excluded (Figure 1). 
Eleven articles, which described seven studies, were included in this review.  
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Abbreviations: n: number, MS: multiple sclerosis 
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-
Analyses flowchart of screening and inclusion process for review (Moher et 
al., 2009). 
 
Of the included articles four were RCTs) (described by seven articles) (Bansi et 
al., 2017; Collett et al., 2011; Farup et al., 2016; Feltham et al., 2013; 
Skjerbæk et al., 2014; Wens et al., 2015; Wens et al., 2017; Zimmer et al., 
2017), one was a randomised crossover trial (Collett et al., 2017) and two were 
cohort studies (Keytsman et al., 2017; Zaenker et al., 2016).  
Articles excluded by title 
(n = 575): 
Not MS (n= 348), not 
exercise (n = 168), not a 
trial (n = 51), not human 
study (n = 8) 
 
Articles excluded by 
abstract (n = 58): 
Not MS (n = 10), not 
exercise (n = 7), not a 
trial (n= 14), resistance 
exercise (n = 12), 
conference abstract (n = 
7), balance/core exercise 
(n = 8) 
Full-text articles excluded  
(n = 27): 
Mixed moderate intensity 
circuits (n = 5), steady 
state exercise (n = 17), 
moderate interval training 
(n = 5) 
Articles included in 
review 
(n = 11) 
Articles identified through database searching (n = 935)  
Additional records identified through reference list (n = 1) 
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PEDro scores ranged from three to eight out of ten (Table 2). Eight articles were 
regarded to be of high quality with a score of seven (Bansi et al., 2017; Feltham 
et al., 2013; Skjerbæk et al., 2014; Wens et al., 2015; Wens et al., 2017) or 
eight (Collett et al., 2011; Farup et al., 2016; Zimmer et al., 2017). Points were 
commonly lost due to a lack of blinding of participants and therapists. All 
articles were included in the review regardless of PEDro score.  
Table 2. Quality assessment of articles using the PEDro scale. 
Lead author, year C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 Total 
Collet, 2011 Y Y Y Y N N Y Y Y Y Y 8 
Feltham, 2013 Y Y Y Y N N Y N Y Y Y 7 
Collet, 2017 Y N Y Y N N N N N Y Y 4 
Wens, 2015 Y Y Y Y N N N Y Y Y Y 7 
Farup, 2016 Y Y Y Y N N Y Y Y Y Y 8 
Wens, 2017 Y Y Y Y N N N Y Y Y Y 7 
Skjerbaek, 2014 Y Y Y Y N N Y Y N Y Y 7 
Zaenker, 2017 Y N N N N N N Y Y N Y 3 
Zimmer, 2017 Y Y Y Y N N Y Y Y Y Y 8 
Bansi, 2017 N Y Y Y N N N Y Y Y Y 7 
Keytsman, 2017 Y N N N N N N Y Y N Y 3 
C1: specification of inclusion criteria; C2: randomisation of participants; C3: concealment of 
allocation; C4: groups similar at baseline; C5: blinding of subjects; C6: blinding of therapists; C7: 
blinding of assessors; C8: one key outcome measure taken for at least 85% of sample; C9: 
intention to treat analysis if appropriate; C10: between group statistical analysis; C11: point 
measures and measures of variability 
 
Three of the studies, reported by seven articles, provided a power calculation 
and had a sample size large enough to be powered (Collett et al., 2011; Farup et 
al., 2016; Feltham et al., 2013; Wens et al., 2015; Wens et al., 2017; Zimmer et 
al., 2017). The other four studies did not report on power (Bansi et al., 2017; 
Collett et al., 2017; Keytsman et al., 2017; Skjerbæk et al., 2014; Zaenker et 
al., 2016). Only one study had a follow up period, which was 12 weeks after 
completion of the intervention (Collett et al., 2011) (Table 3). 
Sample sizes ranged from 11 (Skjerbæk et al., 2014) to 61 (Collett et al., 2011) 
with a total number of 249 participants. Five studies included participants that 
were predominantly mildly disabled (EDSS < 4.0) (Collett et al., 2011; Collett et 
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al., 2017; Farup et al., 2016; Feltham et al., 2013; Keytsman et al., 2017; Wens 
et al., 2015; Wens et al., 2017; Zaenker et al., 2016) one study recruited a 
predominantly moderately disabled group (EDSS 4.0-6.0) (Bansi et al., 2017; 
Zimmer et al., 2017) and one study recruited participants who were more 
severely disabled (EDSS 6.0-8.0) (Skjerbæk et al., 2014) (Table 3). Five studies 
included participants with both relapsing remitting MS  and progressive MS (Bansi 
et al., 2017; Collett et al., 2011; Collett et al., 2017; Farup et al., 2016; 
Feltham et al., 2013; Wens et al., 2015; Wens et al., 2017; Zimmer et al., 2017), 
one study only included participants with progressive MS (Skjerbæk et al., 2014), 
and one study did not report on MS type (Keytsman et al., 2017). A total of 60 
different outcome measures were used across the seven studies.  
All studies conducted HIIT, in a supervised setting, on a cycle ergometer apart 
from Skjerbæk et al. (2014) who used upper limb ergometry. Four studies (eight 
articles) compared HIIT to a form of continuous training (Bansi et al., 2017; 
Collett et al., 2011; Collett et al., 2017; Farup et al., 2016; Feltham et al., 
2013; Wens et al., 2015; Wens et al., 2017; Zimmer et al., 2017), one study 
compared HIIT and in-patient rehabilitation to just in-patient rehabilitation 
(Skjerbæk et al., 2014), and two studies did not have a comparator group 
(Keytsman et al., 2017; Zaenker et al., 2016) (Table 3). Inclusion and exclusion 
criteria of all studies were standard compared to other exercise interventions in 
MS.  
Four studies (eight articles) combined HIIT with another form of exercise 
training; two with resistance training (Farup et al., 2016; Keytsman et al., 2017; 
Wens et al., 2015; Wens et al., 2017), one with continuous moderate intensity 
training (Collett et al., 2011; Feltham et al., 2013), and one with both resistance 
training and continuous moderate intensity training (Zaenker et al., 2016) (Table 
3). 
In terms of exercise dose, the number of training sessions ranged from 1 to 30 
and length of intervention ranged from 3 weeks (Bansi et al., 2017; Zimmer et 
al., 2017) to 12 weeks (Collett et al., 2011; Farup et al., 2016; Feltham et al., 
2013; Keytsman et al., 2017; Wens et al., 2015; Wens et al., 2017; Zaenker et 
al., 2016). Length of exercise interval ranged from 30 seconds (Collett et al., 
2011; Collett et al., 2017; Feltham et al., 2013) to 2 minutes (Farup et al., 2016; 
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Keytsman et al., 2017; Wens et al., 2015; Wens et al., 2017). One study had 
intervals of 3 minutes but only 30-60 seconds of each was spent at a high 
intensity (Skjerbæk et al., 2014). Total time spent in high intensity exercise, 
over the whole intervention, ranged from 10 minutes (Collett et al., 2017) to 225 
minutes (Farup et al., 2016; Keytsman et al., 2017; Wens et al., 2015; Wens et 
al., 2017) (Table 3). 
 
Table 3 Summary of studies included in review and statistically significant results  
Author, 
Year, 
Design 
n,  
Drop-outs,  
Powered 
MS type, 
Disability 
Intervention  
  
Outcome  
Measures, 
Time points 
Statistically significant results 
(mean (SD)) 
Collett et 
al.  
2011 
RCT 3 arm 
 
n=61 
 
Drop out: 6 
 
Pow: Y 
RR: 22 
SP: 25 
PP: 7 
Unknown: 1 
 
Barthel 
index: 19 
Able to walk 
2 min with or 
without aid 
 
 
HIIT vs CONT vs COMB 
12 wks, 2/wk 
Total: 24 sessions 
 
CONT (n=20): 45% peak 
power, 20 min 
HIIT (n=18): 90% peak power 
30sec on 30 sec off, 20 min 
COMB (n=17): 10 min CONT 
a/a followed by 10 HIIT a/a 
 
Pri: 2 min walk 
 
Sec: TUG 
Leg ext power 
Peak power 
 
Barthel Index 
SF36 
FSS 
 
0, 6, 12, 24 
wks 
2 min walk (WG) (p<0.01) 6 wks: HIIT: 
+12.94m (4.71), CONT: +4.71m (4.24), 
COMB: +3.22m (4.60).  Improvements 
maintained at 24 wks 
 
TUG (WG) (p<0.05) 6wks: HIIT: -2.5s (1.8), 
CONT: -3.5s (1.7), COMB: -0.9s (1.9).  
Improvements maintained at 12 wks but 
not 24 
 
Leg power (ALL) (p<0.01) 6 wks: +19.4W 
(4.1), 12 wks: +15.9W (4.1), 24 wks: -
10.9W (3.1) 
 
Peak power (ALL) (p<0.05) 24 wks: -29W 
(5) 
 
SF36: (p<0.05), 12 wks: -4.5 (1.6) 
maintained at 24 wks 
Feltham et 
al.  
2013 
RCT 
Sub-analysis 
of Collett et 
al.  
2011 
RR: 9 
SP: 9 
PP: 3 
 
CONT a/a n=12 
HIIT a/a n=9 
†BP 
RER 
Peak power 
VO2 max 
VO2 peak (ALL) (p =0.05): increase from 
med 8.05ml/kg (2.23) to med 9.2ml/kg 
(3.72) 
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n=21 
 
Barthel 
index: 19 
 
Drop out: 0 
VO2 norm 
HRMax 
 
0, 6, 12 wks 
Peak power (ALL) (p =0.05): increase from 
med 112W (58) to med = 113W (55) 
Collett et 
al.  
2017 
RXT 
 
n=23 
14 with MS 
9 HC 
 
Drop out: 4 
(3 MS, 1 
control) 
 
Pow: N 
RR: 5 
SP:5 
PP:1 
 
Barthel 
index: 19 (1) 
Able to use 
ergometer 
safely 
 
CONT1 vs CONT2 vs HIIT 
3 weeks, 1 session/week 
 
Each participant did as single 
CONT1, CONT2 and HIIT 
session  
 
CONT1: 20 min 45% peak 
power  
CONT2: 20 min 60% peak 
power  
HIIT: 20 min 90% peak power 
(30 sec intervals with 30 sec 
rest) 
†Recovery of: 
HR, Temp, 
RPEbr, RPEleg, 
MEPs 
 
30 sec post 
session then 
every 2 min 
till 10min, 
then every 5 
min till 45 min 
Return to resting HR: 
CONT1: MS in 15 min vs control 4 min 
CONT2: both groups not down to rest HR 
in 45 min 
HIIT: both MS and control return in 30 min 
 
Recovery to baseline RPEleg 
CONT1: MS 6 min vs control 0.5 min 
CONT2: MS 15 min vs control 6 min 
HIIT: MS 35 min vs control 4 min  
 
RPEbr:  
CONT1: MS 8 min vs control 0.5 min 
CONT2: MS 6 min vs control 2 min 
HIIT: MS 6 min vs control 6 min 
 
MEP: 
Return to baseline levels; 
CONT1: both groups in 15 min 
CONT2: MS 15 min vs control 25 min 
HIIT: MS MEP not significantly decreased 
and control recovered in 4 min 
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Temp: 
CONT1: no change 
CONT2: MS group returned to baseline in 
35 min, no change in control 
HIIT: MS group returned baseline in 25 
min, control in 8 min. 
Wens et al. 
2015 
RCT 3 arm 
 
n=34 
 
Drop out: 0 
 
Pow: Y 
RR: 26 
Progressive: 
8 (type of 
progressive 
NR) 
 
EDSS range 
1.0-6.0 
 
Mean EDSS 
2.7 
 
 
SED vs HIIT+RES vs CONT+RES 
12 wks, 5 session/2 wks 
 
SED, n=11: no intervention 
 
HIIT+RES, n=12: 5 x 1 min 
peak power (80-90%HRMax) 
for 6 weeks 
5 x 2 min 100-120% peak 
power (90-100% HRMax) 6 
weeks 
 
CONT+RES, n=11: 6 min at 
80-90% HRMax for first 6 
weeks  
For second 6 weeks 
progressed to 2 x 10 min at 
90-100% HRMax 
 
RES for both ex groups: 
leg presses, curls, 
Pri: Muscle 
fibre CSA and 
proportion 
 
Sec: Isometric 
muscle 
strength 
 
Endurance 
capacity: 
RER 
VO2max 
HRMax 
Test duration 
 
Body 
composition 
 
PA level; 
PASIPD  
 
BG compared to SED: Mean CSA muscle 
fibres 
HIIT: +21% (7) (p<0.05) 
CONT: +23% (5) (p<0.01) 
 
Muscle fibre type I CSA: 
CONT: +29.8% (5.5) (p=0.003) 
 
Muscle fibre type IIa CSA: 
HIIT: 22.8% (6.2) (p<0.05) 
 
BG compared to SED:  
Strength knee flex + ext weak leg: 
HIIT: range +24% (13) to +44% (20) (p= 
0.01 to p=0.006) 
CONT: range +19% (9) to 33% (17) (p= 0.01 
to p=0.006) 
 
Hams strong leg 
HIIT: range +13% (7) to +20% (7) (p=0.006) 
 
 15 
extensions, lateral pull 
downs, arm curls, chest 
presses. Intensity 1 x 10 reps 
max load, progressed to 2 x 
20 reps max load 
0, 12 wks BG compared to SED and CONT: 
Peak power +21% (4) (p = 0.0001) 
Time to exhaustion +24% (5) (p=0.00008) 
VO2max +17% (5) (p=0.001) 
 
Lean tissue mass (WG): 
HIIT + 1.4% (0.5) (p = 0.01) 
Body fat percentage (WG) 
HIIT: -3.9% (2) (p = 0.04) 
CONT: -2.5% (1.2) (p = 0.02) 
 
HRMax (WG) 
CONT: +3.7% SD1.5 
HIIT: +6.2% SD 2.2 
 
PASID (BG vs SED) 
HIIT: 86% (27) (p = 0.004) 
CONT: 73% (19) (p = 0.003) 
Wens et al. 
2017 
Same as 
Wens et al. 
2015 
Same as 
Wens et al. 
2015 
Same as 
Wens et al. 
2015 
Same as Wens et al. 2015 Pri: AUC from 
OGTT 
Fasting 
glucose conc 
 
Sec:GLUT4 
content  
vastus lateralis 
All WG: 
Fasting glucose conc 
HIIT: -7.3% (6.8) (p< 0.05) 
CONT: - 9.0% (6.2) (p< 0.05) 
 
Glucose clearance (AUC)  
HIIT: -6.9% (6.2) (p< 0.05) 
CONT: -11.0% (7.7) (p< 0.05) 
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Insulin (AUC) 
CONT: -12.3% (14.7) (p< 0.05) 
 
Muscle GLUT4 content: 
HIIT: +6.6% (4.5) (p< 0.05) 
Farup et al. 
2016 
Same as 
Wens et al. 
2015 
Same as 
Wens et al. 
2015 but no 
SED group 
HC n=18 
 
Pow: Y 
 
MS mixed no 
SED group 
Combined exercise groups as 
Wens et al 2015  
No SED group 
Pri: SC/type I 
fibre 
SC/type II 
fibre,  
SC/ mm2 type 
I and II fibre 
Myonuclei, and 
central nuclei 
analysis 
 
Sec: Muscle 
tissue fibrosis 
and lipid 
content 
MS(WG): 
SC/type II fibre: +165% (68) (p<0.05) 
SC/mm2 type II fibre: +135% (63) (p< 
0.05) 
 
Lipid content BG MS vs HC 
MS: +117% (37) (p < 0.05). 
Zaenker et 
al.  
2017 
Cohort 
study 
 
n=26 
 
Drop out: 0 
 
Pow: N 
MS mix RR 22 
SP 3 
PP 1 
 
EDSS med 2.0 
(0-5) 
HIIT+RES+CONT 
12 wks 
Wks 1-4: 1 x HIIT and 1x RES 
session/wk 
Wks 5-12: a/a + unsupervised 
CONT or RES session 
 
HIIT: 10 min warm up, 5 x 1 
†VO2 peak 
Peak power 
Peak lactate 
HRMax 
 
Isokinetic 
strength quads 
and hams 
ALL WG as cohort study 
VO2peak +13.5% (p<0.0001) 
Peak power +9.4% (p<.0001) 
Peak lactate +31% (p<0.001) 
HRMax +3.73% (p=0.0120) 
 
Inc strength quads and hams at all torques 
(p<0.05) (size of change not provided) 
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min 90-110% peak power, 3 
min working rest, 5 min 
warm down 
 
RES: body weight exercises, 
2 x hams + 2 x quads.  Start 4 
x 10 reps prog to 5 x 15 reps 
 
CONT: 30-45 min CONT of pt 
choice such as cycling, 
swimming or walking 
 
QoL: SEP 59 
 
0, 12 wks 
SEP 59: Improvement in vitality (p= 
0.0012), emotional well-being (p= 
0.0378), and general well-being (p= 
0.0052) size of change not reported. 
 
Zimmer et 
al. 
2017 
RCT 
n=57 
 
Dropout: 3 
 
Pow: Y 
MS mix 
RR (30) and 
SP (27) 
 
EDSS range 
1.0-6.5 
Mean 4.37 
HIIT vs CONT 
3 Weeks, HIIT 3 x week, 
CONT: 5 x week 
 
HIIT: 20 min, 5x 3 min 
intervals at 85-90% of 
HRMax, with 1.5 min working 
rest at 50-60% HRMax 
CONT: min 70% HRMax 
Pri: BICAMS: 
TMT, TAP test 
(errors and 
speed), SDMT, 
VLMT, BVMT 
 
Sec: Serum 
levels of 
serotonin, 
BDNF, MMP-2, 
MMP-9, 
VO2peak 
 
0, 3 wks 
Time effects 
SDMT 
TMT 
TAP errors 
 
Time x group effect 
Serum MMP-2 in  
HIIT: decreased p=0.009 CI (5.336; 
36.587) 
 
VO2 peak in both groups 
HIIT: p<0.001 CI (–4.096; –2.002) 
CONT: p=0.006 CI (–2.394; –0.426) 
 
VLMT 
HIIT: improvement p=0.046 (CI) (–6.319; –
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0.51)) 
 
TAP errors  
HIIT improved p=0.001 CI (0.508; 1.789) 
 
Bansi et al. 
2017 
Same as 
Zimmer et 
al. 2017 
Same as 
Zimmer et al. 
2017 
 
 
Same as 
Zimmer et al. 
2017 
Same as Zimmer et al. 2017 †HIIT vs CONT: 
within RRMS 
and SPMS 
5HT,Trp, Kyn, 
Kyn/Trp ratio 
RRMS training groups (no diff between 
HIIT or CONT): 
Reduction in Trp (p=0.02) 
Increase in Trp/Kyn ratio (p=0.002)  
Skjerbaek 
et al.  
2014 
RCT 
n=11 
 
Drop out: 1  
 
Pow: N 
PP (n=3) 
SP (n=8) 
 
EDSS 6.5-8.0  
 
HIIT + in-pt rehab vs in-pt 
rehab 
10 sessions over 4 wks, UL 
ergometer HIIT training 
 
6x 3 min intervals: 2 min at 
65-75%VO2max followed by 
30-60 sec sprint of 100% max 
effort 
†VO2 peak, 
HRMax, 
6minWC, 
FSMC, MDI, 
MSIS-29, 9HPT, 
HGT, BBT  
 
0, 4 wks 
Nil 
Keytsman 
et al. 2017 
Cohort 
study 
n=16 
 
Drop out: 0 
 
Pow: N 
MS type: NR 
 
EDSS mean 
2.6  
HIIT+RES 
12 wks, 5 session per 2 wks 
HIIT Wks 1-6: 5 x 1min 85-
90% HRmax, 1 min rest 
Wks 7-12: 5 x 2 min 100% 
HRmax, 1 min rest 
RES: leg presses, curls, 
extensions, lateral pull 
downs, arm curls, chest 
presses. Intensity 1 x 10 reps 
†Body 
composition, 
resting HR, BP, 
OGTT, total 
chol, fasting 
glucose, 
fasting TG, 
HDL, LDL, 
insulin 
All p<0.05 
Resting HR: -6% (bpm) 
2 hr glucose conc: -13% (mmol/l) 
Insulin sensitivity: -24%  
WMax; +25 W (CI -34, -16) 
t to exhaustion: +2 min (CI-3,-1) 
VEmax: 15 l/min (CI-23,-7) 
Isometric and isokinetic strength 
increased in both legs 
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max load, progressed to 2 x 
20 reps max load after 6 wks 
sensitivity, 
Wmax, HRMax, 
VO2max, RER, 
peak lactate, t 
to exhaustion, 
VEmax 
Isometric and 
isokinetic 
strength of 
legs ext and 
flex, PASID 
 
Peak lactate +2.1 mmol/l 
RER: -0.04  
VO2max: +5.9 ml/min/kg 
† Outcome measures in these studies were not separated into primary and secondary outcome measures 
Abbreviations: RCT: randomised controlled trial; RXT: randomised crossover trial; n: number of participants; Pow: statistically powered; a/a: as above; HC: healthy 
controls; RR; relapsing remitting; SP: secondary progressive; PP: primary progressive; Pri: primary outcome measure; Sec: Secondary outcome measure; min: 
minute; NR: not reported; EDSS: expanded disability status scale; HIIT: high intensity interval training; SED: sedentary; med: median; CONT: continuous moderate 
intensity training; COMB: combination; wk: week; sec: second; RES: resistance training; HRMax: maximal heart rate; VO2max: maximal volume oxygen consumed 
VO2: volume of oxygen consumed; TUG: timed up and go test; ext: extension; SF36: short form 36; FSS: fatigue severity scale; BP: blood pressure; RER: respiratory 
exchange ratio; HR: heart rate; temp: temperature; RPEbr: borg scale of perceived exertion breathing; RPEleg: borg scale of perceived exertion legs; MEPs: motor 
evoked potentials; CSA: cross sectional area; PASIPD; Physical Activity Scale for Individuals with Physical Disabilities; OGTT: oral glucose tolerance test; conc: 
concentration; SC: satellite cells; quads: quadriceps; hams: hamstrings; SEP: Sclerose En Plaques-59; BICAMS: brief international cognitive assessment for MS; TMT: 
trail making test; TAP: Test of Attentional Performance; SDMT: symbol digit modalities test; VLMT: California verbal learning memory test; BVMT: Brief visuospatial 
memory test-revised; BDNF: brain derived neurotrophic factor; MMP: matrix metalloproteinases; 6minWC: 6 minute wheelchair test; 5HT: serotonin; Trp; 
tryptophan; Kyn; kynurenine; FSMC: fatigue scale of motor and cognitive function; MDI: major depression inventory; MSIS-29: multiple sclerosis impact scale; 9HPT: 
9 hole peg test; HGT: hand grip test; BBT: box and block test; HDL: high density lipoprotein; LDL: low density lipoprotein; TG: triglyceride; chol: cholesterol; 
VEmax: maximal expiratory volume W: watts; WG: within group analysis; BG: between group analysis: CI: confidence interval 
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One study reported six adverse events (Collett et al., 2011; Feltham et al., 2013). 
Four were knee or leg pain while cycling, which were deemed to be possibly 
related to the intervention. Two of the adverse events were, deemed by the 
researchers as, unrelated to the intervention (one exacerbation of symptoms and 
one loss of consciousness). The other six studies reported that there were no 
adverse events in either their intervention or control groups (Bansi et al., 2017; 
Collett et al., 2017; Farup et al., 2016; Keytsman et al., 2017; Skjerbæk et al., 
2014; Wens et al., 2015; Wens et al., 2017; Zaenker et al., 2016; Zimmer et al., 
2017).  
The retention of participants within the studies was high; one study had a drop out 
of greater than 10% (Collett et al., 2017), two studies less than 10% (Bansi et al., 
2017; Collett et al., 2011; Feltham et al., 2013; Zimmer et al., 2017), while four 
studies had no drop outs (Farup et al., 2016; Keytsman et al., 2017; Skjerbæk et 
al., 2014; Wens et al., 2015; Wens et al., 2017; Zaenker et al., 2016) (Table 3). 
Details of all statistically significant changes in outcomes measures are presented 
in Table 3.   
Six studies measured either VO2peak or VO2max (Bansi et al., 2017; Collett et al., 
2011; Farup et al., 2016; Feltham et al., 2013; Keytsman et al., 2017; Skjerbæk et 
al., 2014; Wens et al., 2015; Wens et al., 2017; Zaenker et al., 2016; Zimmer et 
al., 2017). One of the RCTs reported an improvement, compared to both the 
sedentary and continuous training groups, in VO2max in their HIIT group (+17% (SD) 
5, p<0.01) (Farup et al., 2016; Wens et al., 2015; Wens et al., 2017). Two RCTs 
reported an improvement of VO2peak in both their HIIT and continuous training 
groups ((median 8.05 ml/kg - 9.2 ml/kg (Collett et al., 2011; Feltham et al., 
2013)), (HIIT (95% CI (–4.096; –2.002) p<0.001), continuous (95% CI (–2.394; –0.426) 
p=0.006) (Bansi et al., 2017; Zimmer et al., 2017)). The two cohort studies found 
improvements, one in VO2peak (+13.5% (p<0.0001) (Zaenker et al., 2016), and the 
other in VO2max (+5.9 ml/min/kg (p<0.05 (Keytsman et al., 2017)). Conversely, 
one RCT reported no change in the VO2peak of their HIIT group (Skjerbæk et al., 
2014) (Table 3). 
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Two of the five studies which measured HRMax found significant within group 
increases in their HIIT group, indicating a probable learning effect of exercising to 
greater intensities (Whyte et al., 2008); (+3.73%, p=0.012 (Zaenker et al., 2016), 
+6.2%, p=0.05 (Farup et al., 2016; Wens et al., 2015; Wens et al., 2017)). The 
other three studies which measured HRMax did not find changes after their HIIT 
intervention (Collett et al., 2011; Feltham et al., 2013; Keytsman et al., 2017; 
Skjerbæk et al., 2014) (Table 3).   
Peak power, was measured in four studies (Collett et al., 2011; Farup et al., 2016; 
Feltham et al., 2013; Keytsman et al., 2017; Wens et al., 2015; Wens et al., 2017; 
Zaenker et al., 2016). One RCT reported an increase, compared to their sedentary 
and continuous training groups, in peak power after the intervention (+21% (SD 4) 
(p<0.01) (Farup et al., 2016; Wens et al., 2015; Wens et al., 2017)) and the two 
cohort studies also reported an increase in peak power (+9.4%, p<0.0001, (Zaenker 
et al., 2016), +25 W (CI -34, -16), p<0.05 (Keytsman et al., 2017)). The RCT by 
Collett et al. (2011) initially found no differences in peak power post intervention, 
however, subsequent analysis demonstrated that peak power was increased in 
participants who completed more than 8 sessions, (median 112 W to median 113 
W, p=0.05) (Feltham et al., 2013) (Table 3).  
All four studies that examined muscle strength reported improvements following 
the intervention (Collett et al., 2011; Farup et al., 2016; Feltham et al., 2013; 
Keytsman et al., 2017; Wens et al., 2015; Wens et al., 2017; Zaenker et al., 2016). 
Collett et al. (2011) and Feltham et al. (2013) reported improvements in isometric 
leg extension power at the end of the intervention but this was not maintained at 
a 12 week follow up (12 weeks: +15.9W SD 4.1, 24 weeks: -10.9W SD 3.1, p<0.01). 
One study found an increase in isometric hamstring strength in the HIIT group only 
(range +13% Nm, (SE 7) to +20% (SE 7), p=0.006) and between group differences in 
the quadriceps and hamstring of the weak leg in both the HIIT (range +24% Nm, SE 
13, p=0.01, to +44% Nm, SE 20 p=0.006) and high intensity continuous groups 
(range +19% Nm, SE 9 p= 0.01, to 33% Nm, SE 17 p=0.006) (Wens et al., 2015). Both 
cohort studies found improvements in muscle strength (Keytsman et al., 2017; 
Zaenker et al., 2016). Keytsman et al. (2017) reported stronger isometric 
hamstring contractions in the stronger leg at 90 degrees, in quadriceps at 45 
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degrees, and both muscle groups in maximal isokinetic contractions. In the weaker 
leg stronger isometric hamstring and quadriceps contractions were found at both 
45 and 90 degrees along with stronger hamstring isokinetic contractions (p<0.05). 
Zaenker et al. (2016) reported increases in the strength of quadriceps and 
hamstrings of both legs at three different torques of 90, 180 and 240 degrees per 
second (p<0.05) (Table 3). 
 
4 Discussion 
This was the first systematic review for the use of HIIT in MS. Overall, the seven 
studies included in the review provided positive evidence for the use of HIIT in 
people with MS. All studies except one (Skjerbæk et al., 2014) found 
improvements in multiple outcome measures. Predominantly improvements were 
observed in outcome measures relating to fitness. It should however, be noted that 
fitness outcome measures were not primary outcomes in any of the studies 
included. High intensity interval training was well tolerated with adverse events 
only occurring in one study (Collett et al., 2011; Feltham et al., 2013). Previous 
research has shown that HIIT is safe in healthy individuals (Milanovic et al., 2015), 
people with chronic heart failure (Smart et al., 2013), coronary artery disease 
(Elliott et al., 2015), and increased cardio-metabolic risk (Weston et al., 2014). 
Due to the low incidence of adverse events, this review suggests that HIIT is also 
safe in people with MS. 
The evidence in this review is positive for the use of HIIT in increasing 
cardiovascular fitness in people with MS. Five of the six studies that measured 
cardiovascular fitness reported improvements in at least one outcome measure 
(Bansi et al., 2017; Collett et al., 2011; Farup et al., 2016; Feltham et al., 2013; 
Keytsman et al., 2017; Wens et al., 2015; Wens et al., 2017; Zaenker et al., 2016; 
Zimmer et al., 2017). Skjerbæk et al. (2014), who measured both VO2peak and 
HRMax, did not find statistically significant changes, although a trend towards 
statistical significance for VO2peak was reported (p=0.06, data not in Table 3. This 
study however differed from the others as the participants had progressive MS and 
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were the most disabled and deconditioned. Furthermore, the study was 
underpowered and had one of the lowest time exercising at high intensity over the 
whole intervention (60 minutes). A similar low time at high intensity was used by 
Zaenker et al. (2016), but with the addition of continuous and resistance training 
elements to the intervention.  
Skjerbæk et al. (2014) was also the only study to use arm ergometry, whereas the 
other studies used cycle ergometry. Arm ergometry is a practical modality of 
exercise for those with mobility problems but engages smaller muscles than leg 
cycling ergometry, resulting in lower energy expenditure and thus creating less 
demand on the cardiorespiratory system. Indeed, a previous study comparing arm 
ergometry, leg cycling and rowing at a moderate intensity in people with 
progressive MS, found that the leg cycling group increased their VO2max while no 
changes were found in the arm ergometry and rowing groups (Briken et al. 2014). 
Further research is warranted to investigate the efficacy of using upper limb 
ergometry for delivering HIIT for people with higher levels of disability/progressive 
MS. 
Previous research comparing HIIT to continuous moderate intensity training in 
other conditions has quantified the effectiveness via meta-analyses. For example, 
in healthy individuals HIIT is more effective than continuous moderate intensity 
training in increasing VO2max by 4.5 ml/kg/min (Milanovic et al., 2015) and in 
people with increased cardiometabolic risk, HIIT is more effective in increasing 
VO2peak by 3.03 ml/kg/min (Weston et al., 2014). While the evidence for HIIT in 
people with MS is positive, due to the heterogeneity of outcome measures and the 
lack of control groups in two of the studies, a meta-analysis was not possible or 
appropriate. This makes comparison of the effect of HIIT between MS and other 
conditions difficult.  
All four studies that measured muscle strength reported improvements (Collett et 
al., 2011; Farup et al., 2016; Feltham et al., 2013; Keytsman et al., 2017; Wens et 
al., 2015; Wens et al., 2017; Zaenker et al., 2016). One of these did not 
specifically include a resistance training element (Collett et al., 2011; Feltham et 
al., 2013), but still reported an increase in isometric muscle strength. This may 
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indicate that aerobic HIIT could be effective in increasing leg muscle strength. This 
is in line with HIIT research in healthy populations which demonstrated an increase 
in muscle strength following a HIIT cycling intervention (Herbert et al., 2017; 
Wright et al., 2016). As working muscles at a higher intensity produces greater 
increases in strength (Garber et al., 2011), the increase in strength from HIIT is 
likely induced from cycling at a higher workrate during the high intensity intervals, 
compared to continuous moderate intensity training.  
Only one study (published over two articles) examined the effect of HIIT on 
neurochemicals related to MS, exploring the effects of HIIT on levels of serotonin, 
BDNF, metalloproteinase 2 and 9, and tryptophan metabolism (Bansi et al., 2017; 
Zimmer et al., 2017). The researchers reported, that compared to the continuous 
training group, the HIIT group improved their level of matrix metalloproteinase 2. 
As the intervention and control undertook an exercise programme of equal energy 
expenditure this suggests that higher intensity of exercise could have a more 
beneficial effect on neurological markers. The cohort study by Keytsman et al. 
(2017) measured the effect of HIIT on lipid profiles but did not report any 
significant changes (Keytsman et al. (2017). This trial was however, underpowered 
and had no control group. Both of these areas of research warrant further 
investigation, particularly since a previous review concluded that the evidence was 
inconclusive for the effect of aerobic exercise on BDNF in people with neurological 
conditions (Mackay et al., 2017) and a previous work on the effect of exercise on 
blood lipids in people with MS is also inconclusive (Wens et al., 2013).  
 
4.1 Limitations 
The heterogeneity of the outcome measures used across the seven studies limited 
comparison with previous reviews of HIIT in other conditions and prevented a 
meta-analysis. The lack of power calculations in some studies also limited the 
applicability of results in this patient population. Lastly, four of the seven studies 
combined HIIT with another form of exercise training, thus making it difficult to 
draw conclusions on the specific effect of HIIT. 
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5 Conclusion 
The evidence presented in this review suggests that HIIT, via cycle ergometry, is a 
safe and effective way of improving fitness in people with MS and requires fewer, 
shorter training sessions compared to a moderate intensity, continuous training 
mode to gain benefits. Further investigation of HIIT is required in people with 
progressive MS and/or those with a moderate and severe level of disability. In 
addition, future research should examine the possible benefits of HIIT in people 
with MS, beyond cardiovascular fitness and muscle strength. 
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